Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Mol Pharm. 2011 Nov 15;8(6):2444–2453. doi: 10.1021/mp200401p

Figure 2.

Figure 2

A) Competition experiments of the compounds 2, 6 and 9 in the presence of 250 nM of Ac-TZ14011-MSAP (3). B) Saturation binding experiments of compounds 3, 7 and 10. C and D) Cell viability of MDAMB231CXCR4+ cells in the presence of different concentrations compounds 2, 6 and 9 (C) and compounds 3, 7 and 10 (D). For all graphs the bars represent average ± SD.